Pregabalin Terminated Phase 3 Trials for Epilepsies Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00372528An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures